The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

New hair regrowth therapies show promise but need more research.

Hair transplants now offer natural, lasting results with high satisfaction due to advanced techniques and therapies.

Botulinum toxin shows promise for treating scalp sweating but not for hair growth.

Genetic predictions of baldness in Europeans don't apply well to African men.

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.

Genetic factors and diet significantly increase the risk of male pattern baldness.

Low-level laser therapy helps increase hair density in androgenetic alopecia.

A specific genetic marker is linked to male pattern baldness in Han Chinese men.

New regenerative therapies show promise for treating hair loss.

Certain genes may influence hair loss differently in men and women.

Low SULT activity in hair follicles leads to better response to oral minoxidil for hair loss.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Retinoic acid helps activate hair growth in people with common hair loss by working on a specific cell growth pathway.

Identified genes linked to male-pattern baldness may help develop new treatments.

Genetic factors could lead to personalized treatments for hair loss.

Platelet-rich plasma may improve hair density and count in male pattern hair loss, but more high-quality research is needed.

Using both minoxidil and finasteride together is more effective for hair growth than using either one alone in men with hair loss.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Different genes cause Female Pattern Hair Loss compared to male hair loss, and treatments vary, but more research is needed to understand it fully.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Ageing and increased senescent cells significantly contribute to common hair loss.

Targeting specific genes in certain pathways may help treat male pattern baldness.

Human nails and hair follicles have similar gene activity, especially in the cells that contribute to their growth and development.

Two specific genetic markers increase the risk of hair loss in Asian populations.

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

Using both minoxidil and flutamide together is more effective for treating hair loss than using minoxidil alone.

Enzyme booster SULT1A1 greatly enhances hair regrowth with minoxidil.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Finasteride and minoxidil together safely and effectively increase hair growth and density for androgenetic alopecia.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Finasteride side effects in young men may be linked to specific gene variations.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Sulfotransferase in hair follicles helps predict how well minoxidil works for female hair loss.

No link found between new male baldness genes and female hair loss.

New test predicts if hair loss treatment will work.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Genetic variants at 20p11 increase baldness risk in Chinese Han people.

Hair loss risk is influenced by multiple genes.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

AR/EDA2R gene linked to early-onset female hair loss, but 20p11 gene not involved.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

A gene called HDAC9 might be a new factor in male-pattern baldness.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Hair loss gene found on chromosome 3q26.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.

Male pattern baldness is largely genetic, linked to the androgen receptor gene, and may relate to certain health issues.

Gene differences may affect baldness treatment response in Korean men.

Male pattern baldness is linked to specific genetic variations in the androgen receptor gene.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

Hair follicle biology advancements may lead to better hair growth disorder treatments.